Navigation Links
Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes
Date:1/19/2010

ulti-disorders.  "We are pleased to partner with Axxam and JDRF to advance the development of new treatments for T1D and MS," said Dr. Timothy Coetzee, President of Fast Forward.  Adds Dr. Coetzee, "People with MS and T1D need more treatment options and the approach taken by Axxam holds great promise for both diseases."

"Our partnership with Fast Forward and Axxam opens exciting new avenues for JDRF to speed the translation of basic research into drugs and treatments for type 1 diabetes," said Alan J. Lewis, PhD, President and Chief Executive Officer of JDRF.  "Research into the Kv1.3 ion channel has the potential to negate the autoimmune process causing type 1 diabetes and multiple sclerosis, which must be addressed to cure these diseases."

"It's rewarding for Axxam to be working with two world class non-profits dedicated to speeding new therapies to their constituencies," said  Dr. Stefan Lohmer, Ph.D., Chairman and Chief Executive Officer of Axxam. "This collaboration recognizes the quality of our research in the challenging ion channels field and we hope to be on the cusp for developing potential new therapies for both type 1 diabetes and multiple sclerosis."

About JDRF:

JDRF is the worldwide leader for research to cure type 1 diabetes.  It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research.  Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal.  Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump -- each day, every day of their l
'/>"/>

SOURCE Juvenile Diabetes Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
2. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
3. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
4. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
5. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
6. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
7. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
8. Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes
9. Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors
10. deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
11. 183 New Medicines in Development for Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  Healthgrades, the leading ... and connect with physicians and hospitals, today issued ... in" When Making Healthcare Decisions to Get Your ... performing hospitals for maternity care, gynecologic surgery, as ... of women across 15 of the most common ...
(Date:6/18/2013)... 18, 2013  Pro football player and 2012 most ... family expert Jo Frost have potentially life-threatening ... the fully integrated specialty pharmaceutical business of Mylan Inc. ... this significant health problem. In recognition of the 25 ... Administration (FDA) approval of EpiPen ® (epinephrine) Auto-Injector, ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
(Date:6/18/2013)... in the mammary gland appear to provide a crucial ... life, and the subsequent development of breast cancer, researchers ... 2013 issue of the journal Cancer Prevention Research ... associated with an increased risk of certain types of ... of social stress to cancer have been hard to ...
(Date:6/18/2013)... Brandeis research scientist Daniel Perlman has discovered a way ... and foods that are consumed by humans, potentially opening ... , A U.S. patent (#8,460,738) on the new process ... , Phytosterols in plants and cholesterol molecules in animals ... they are attracted to one another. When they mix ...
(Date:6/18/2013)... computer guided fitness training system using a person,s ... winners of the LeWeb,13 London Startup Competition, Europe,s ... startup company, Genetrainer, building on University of Bristol ... Pethica and Julian Gough, Professor of Bioinformatics in ... from over 350 startups to be one of ...
(Date:6/18/2013)... Dr. Farooq Ashraf, an Atlanta LASIK surgeon ... pleased to announce that he is offering his patients ... the iFS™ Advanced Femtosecond Laser. Currently, the Atlanta Vision ... offer its patients this new technology, and for a ... complimentary upgrade to the Advanced Femtosecond Laser. Ordinarily, procedures ...
(Date:6/18/2013)... Visitors to New York can experience luxury and the utmost in ... Marriott Essex House New York . , While in the ... can take a break from the hustle and bustle to treat ... at Essex House. A new Indulge in NYC Package ... per night plus a $150 spa credit and 20 percent off ...
Breaking Medicine News(10 mins):Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Brandeis scientist invents anti-cholesterol process 2Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 3
... (HealthDay News) -- The ability to make decisions in new ... brain,s white matter, a new imaging study says. The ... a learning task involving money and also undergo MRI brain ... associated with the weakening of two specific white-matter pathways that ...
... , TUESDAY, April 17 (HealthDay News) -- A ... the spread of the AIDS-causing virus, but would only ... risk for HIV infection, according to a new study. ... analyze the use of the combination drug tenofovir-emtricitabine (brand ...
... , TUESDAY, April 17 (HealthDay News) -- A vaccine made ... nearly 50 percent improvement in survival times for those stricken ... of U.S. Sen. Edward Kennedy, a new study suggests. ... recurrent glioblastoma -- an aggressive brain cancer that typically kills ...
... the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) ... did not lead to significantly increase survival rates for patients ... study by Dana-Farber Cancer Institute researchers has found. The ... of the American Medical Association , a these issue on ...
... A new evaluation by London School of Hygiene & ... 2010 Haiti earthquake, finds that many hands didn,t always ... during and after the 2010 earthquake, and physical rehabilitation ... sector alone involved 125 organisations including UN agencies, government, ...
... cocktails during an individual,s early 20s doesn,t correlate to ... doesn,t stop as they reach age 30, young adults ... Missouri study. Helping young adults acknowledge their mental impulse ... abuse intervention programs. "When a heavy drinking 30-year-old ...
Cached Medicine News:Health News:HIV Prevention Pill Cost-Effective for High-Risk Men: Study 2Health News:Brain Tumor Vaccine Shows Promise in Early Trial 2Health News:Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients 2Health News:Good intentions bring mixed results for Haiti's disabled people 2Health News:Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments 2
... and Response catheters comprise the world's ... for electrophysiology procedures. Their advanced catheter ... superior torque response with a soft, ... and French sizes, Supreme and Response ...
Lumenis 950 Slit Lamp Zeiss-style diagnostic slit lamp biomicroscope with parallel optics and offering a choice of automatic or fixed eye safety filters for multiple wavelengths....
... Nd:YAG Base Platform is an ... the anterior segment of the ... of secondary cataracts and performing ... offers multiple upgrade options that ...
... Catheter Delivery System (CDS) facilitates ... of the Aescula LV Left-Heart ... a patented coronary sinus curve ... easy access to the coronary ...
Medicine Products: